Reference results for Pertuzumab from Search.com.

HER2+ Breast Cancer Treatment | PERJETA® (pertuzumab)

www.perjeta.com

Learn about PERJETA®, a neoadjuvant and metastatic breast cancer treatment for patients with HER2-positive breast cancer. What does PERJETA treat? PERJETA ...

Pertuzumab - Wikipedia, the free encyclopedia

https://en.wikipedia.org/wiki/Pertuzumab

Pertuzumab (also called 2C4, trade name Perjeta) is a monoclonal antibody marketed by Genentech for the treatment of HER2-positive breast cancer, in combination with ...

Pertuzumab - National Cancer Institute

www.cancer.gov/about-cancer/treatment/drugs/pertuzumab

This page contains brief information about pertuzumab and a collection of links to more information about the use of this drug, research results, and ...

Pertuzumab (Perjeta) Chemotherapy Drug Information

chemocare.com/chemotherapy/drug-info/Pertuzumab.aspx

Pertuzumab (Perjeta) side effects, what it’s used for, how it’s given, how it works, drug type, precautions and self care tips

Pertuzumab - Food and Drug Administration

www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm307592.htm

Pertuzumab. On June 8, 2012, the U. S. Food and Drug Administration approved pertuzumab injection (PERJETA, Genentech, Inc.) for use in combination with trastuzumab ...

Pertuzumab: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/pertuzumab.html

Easy to read patient leaflet for pertuzumab. Includes indications, proper use, special instructions, precautions, and possible side effects.

Pertuzumab (Perjeta) | Cancer Research UK

www.cancerresearchuk.org/.../treatment/cancer-drugs/pertuzumab-perjeta

Read about the cancer treatment drug pertuzumab, also called Perjeta, including what it is, how it works and possible side effects.

Pertuzumab - Side Effects, Dosage, Interactions | Everyday ...

www.everydayhealth.com/drugs/pertuzumab

Pertuzumab is a cancer medication that interferes with the growth and spread of cancer cells in the body. Pertuzumab is used together with other cancer medicines ...

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive ...

www.nejm.org/doi/full/10.1056/NEJMoa1413513

Original Article from The New England Journal of Medicine — Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

FDA Approval for Pertuzumab - National Cancer Institute

www.cancer.gov/about-cancer/treatment/drugs/fda-pertuzumab

Brand name: Perjeta® Approved for use in combination with trastuzumab and doctaxel neoadjuvant treatment of HER2-positive breast cancer; Approved for use in ...